Shanrong Biotechnology Valuation
| SRBT Stock | USD 1.00 0.45 81.82% |
Today, the company appears to be overvalued. Shanrong Biotechnology has a current Real Value of $0.8 per share. The regular price of the company is $1.0. Our model measures the value of Shanrong Biotechnology from inspecting the company fundamentals such as Current Valuation of 914.35 K, net income of (31.75 K), and Cash Per Share of 0.04 X as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Shanrong Biotechnology's price fluctuation is out of control at this time. Calculation of the real value of Shanrong Biotechnology is based on 3 months time horizon. Increasing Shanrong Biotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Shanrong Biotechnology's intrinsic value may or may not be the same as its current market price of 1.00, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0 | Real 0.8 | Hype 1.12 | Naive 1.09 |
The intrinsic value of Shanrong Biotechnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Shanrong Biotechnology's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Shanrong Biotechnology Corp helps investors to forecast how Shanrong pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Shanrong Biotechnology more accurately as focusing exclusively on Shanrong Biotechnology's fundamentals will not take into account other important factors: Shanrong Biotechnology Total Value Analysis
Shanrong Biotechnology Corp is at this time forecasted to have valuation of 914.35 K with market capitalization of 380.98 K, debt of 2.22 M, and cash on hands of 30.87 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Shanrong Biotechnology fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
914.35 K | 380.98 K | 2.22 M | 30.87 K |
Shanrong Biotechnology Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of Shanrong implies not a very effective usage of assets in January.Shanrong Biotechnology Profitability Analysis
Net Loss for the year was (31.75 K) with profit before overhead, payroll, taxes, and interest of 0.About Shanrong Biotechnology Valuation
The pink sheet valuation mechanism determines Shanrong Biotechnology's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Shanrong Biotechnology based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Shanrong Biotechnology. We calculate exposure to Shanrong Biotechnology's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Shanrong Biotechnology's related companies.Shanrong Biotechnology Corp. operates as a project management and executive consulting company. Shanrong Biotechnology Corp. is based in Beverly Hills, California. Shanrong Biotechnology operates under Shell Companies classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Shanrong Biotechnology's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Shanrong Biotechnology's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Shanrong Biotechnology's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Shanrong Biotechnology's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Shanrong Biotechnology's revenue streams: Identify Shanrong Biotechnology's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Shanrong Biotechnology's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Shanrong Biotechnology's growth potential: Evaluate Shanrong Biotechnology's management, business model, and growth potential.
- Determine Shanrong Biotechnology's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Shanrong Biotechnology's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Shanrong Biotechnology Growth Indicators
Investing in growth stocks can be very risky. If the company such as Shanrong Biotechnology does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Retained Earnings | -5.6 M |
Additional Tools for Shanrong Pink Sheet Analysis
When running Shanrong Biotechnology's price analysis, check to measure Shanrong Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanrong Biotechnology is operating at the current time. Most of Shanrong Biotechnology's value examination focuses on studying past and present price action to predict the probability of Shanrong Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanrong Biotechnology's price. Additionally, you may evaluate how the addition of Shanrong Biotechnology to your portfolios can decrease your overall portfolio volatility.